OPKO Health
OPK
#6316
Rank
โ‚ฌ0.89 B
Marketcap
1,20ย โ‚ฌ
Share price
1.46%
Change (1 day)
7.57%
Change (1 year)

EPS for OPKO Health (OPK)

EPS in 2026 (TTM): -0,23ย โ‚ฌ

According to OPKO Health 's latest financial reports the company's current EPS (TTM) is -0,23ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -0,26ย โ‚ฌ a decrease over its 2024 EPS that were of -0,06061ย โ‚ฌ.

EPS history for OPKO Health from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,23ย โ‚ฌ-11.4%
2025-0,26ย โ‚ฌ328.57%
2024-0,06061ย โ‚ฌ-72%
2023-0,22ย โ‚ฌ-43.18%
2022-0,38ย โ‚ฌ780%
2021-0,04329ย โ‚ฌ-200%
20200,04329ย โ‚ฌ-109.43%
2019-0,46ย โ‚ฌ96.3%
2018-0,23ย โ‚ฌ-49.06%
2017-0,46ย โ‚ฌ1225%
2016-0,03464ย โ‚ฌ-54.06%
2015-0,07539ย โ‚ฌ-78.23%
2014-0,35ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
7,56ย โ‚ฌ-3,335.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
3,12ย โ‚ฌ-1,436.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
36,83ย โ‚ฌ-15,851.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
3,08ย โ‚ฌ-1,418.52%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
9,84ย โ‚ฌ-4,307.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
3,28ย โ‚ฌ-1,503.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
1,19ย โ‚ฌ-607.41%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Ardelyx
ARDX
-0,20ย โ‚ฌ-14.81%๐Ÿ‡บ๐Ÿ‡ธ USA